Skip to content

Changes in neuropsychological profile of persons with opioid use disorder after abstinence from opioid

Effect of abstinence from opioid on neuropsychological profile of persons with opioid use disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/05/033633
Enrollment
50
Registered
2021-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F112- Opioid dependence

Interventions

None listed

Sponsors

Department of Psychiatry
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: The patient should be willing to give consent for the study. The patient should not be intoxicated or in severe withdrawal at the time of intake as well as before neuropsychological assessments at 2 and 8 weeks. (COWS score The patient should be accompanied by a family member or caregiver. 6 years of formal education of patient required.18 Patient willing to provide urine sample for the screening of opioid.

Exclusion criteria

Exclusion criteria: Patient with co-morbid dependence on other substances except for nicotine and caffeine. A patient diagnosed with any active major mental illness (psychotic or bipolar disorders, dementia) which causes impairment in neuropsychological profile. Presence of evidence of sub-normal intelligence. Patient with history of diagnosis with medical conditions including cerebrovascular diseases, neurodegenerative diseases, head injury with a concussion, epilepsy/seizure disorder, Parkinsonism, systemic illness and any other organic disease which can impair the neuropsychological profile. The patient who test positive for HIV. Actively suicidal cases.

Design outcomes

Primary

MeasureTime frame
Neuropsychological profile focusing on impairment in 4 tests, Wisconsin card sorting test (NIMHANS battery), Digit Span Test (PGIBBD), Recognition test (PGIBBD), Verbal retention for similar and dissimilar pairs (PGIBBD) Timepoint: Baseline, 2 weeks, 8 weeks

Secondary

MeasureTime frame
Changes on Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES 8D)(personal drug use questionnaire), Severity of opioid dependence questionnaire(SODQ), The Opioid Craving Scale(OCS), International Index of Erectile Dysfunction ( IIEF). Timepoint: Baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks

Countries

India

Contacts

Public ContactGurneet kaur

Government medical college and hospital, sector 32, Chandigarh

ajeetsidana@hotmail.com9646121614

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026